Characteristics and comparative study of medicinal materials between China and India based on data mining from literatures.

ETHNOPHARMACOLOGICAL RELEVANCE: China and India have unique traditional medicine systems with vast territory and rich medical resources. Traditional medicines in China include traditional Chinese medicine, Tibetan medicine, Mongolian medicine, Uyghur medicine, Dai medicine, etc. In the third national survey of Chinese medicine resources, 12694 medicinal materials were identified. Traditional medicines in India include Ayurveda, Unani, Siddha, Homoeopathy, etc. There are 7263 medicinal materials in India. AIM OF THE STUDY: To reveal the characteristics of medicinal materials between China and India respectively, and to compare the similarities and differences in terms of properties, tastes, medicinal parts and therapeutic uses and to promote the exchange of traditional medicine between China and India and the international trade of traditional medicine industry. METHODS: The information of medicinal materials between China and India was extracted from The Chinese Traditional Medicine Resource Records and Pharmacopoeia of the People's Republic of China, as well as from 71 Indian herbal monographs. The information of each medicinal material, such as types, families, genera, properties, distribution, medicinal parts, efficacy, therapeutic uses, dosage form and dosage, was recorded in Excel for statistical analysis and visual comparison. RESULTS: A total of 12694 medicinal materials in China and 5362 medicinal materials in India were identified. The medicinal materials were mostly distributed in Southwest China and northern India. Plants were the main sources of medicinal materials. The common medicinal parts in China were whole medicinal materials, roots and rhizomes, and India used more renewable fruits, seeds and leaves. They are commonly used in the treatment of digestive system diseases. There were 1048 medicinal materials used by both China and India, which were distributed in 188 families and 685 genera. The Chinese and Indian pharmacopoeias had a total of 80 species of medicinal materials used by both China and India. CONCLUSIONS: The characteristics of medicinal materials between China and India were somewhat different, which was conducive to provide a reference basis for traditional medicine in China or India to increase the medicinal parts and indications when using a certain medicinal material, as well as to expand the source of medicine and introduce new resources. However, there were certain similarities and shared medicinal materials, which can tap the potential of bilateral trade of medicinal materials between China and India, so as to promote the medical cultural exchange and economic and trade cooperation between the two countries.

[Exploration on an overview of history (from Chunqiu to Ming and Qing Dynasties) and species of Chinese exotic traditional medicine].

This paper collected and analyzed literatures about starting of traditional medicine and trading of different medicine from Chunqiu Zhanguo to Ming and Qing Dynasties, in order to preliminarily explore on an overview of specie of chinese exotic traditional medicine and trade of different country in different dynasty（from Chunqiu to Ming and Qing Dynasties）, as well as the amount of exotic medicine over two thousand years. (remove repeating and doubtful species), find peculiarity of exotic medicine, sreen species that used to develop the Silk Route and establish quality standards.Finally, We get conclusions are as follows. First, primary,.prosperous and declining stages of development of exotic traditional medicine are Qin and Han, Song-Jin-Yuan, Ming and Qing Dynasties, respectively. Second, according to literature, the stage that has the most species of exotic medicine is song dynasty,approximately have 300. Removing repeating and doubtful species, the believable species are approximate 230 to 250. Meanwhile, the unknown species are approximate 30, which may be different name of one medicine or processed goods, now these medicines are named as "doubtful species". Third, the medicinal parts of exotic medicine are different from Chinese medicine of Han nation. The number of Resin, fruits and seeds kind are more than root and rhizomes kind,mineral medicines are more than animal. Fourth, the major producing area of exotic medicine is some countries and territories related to the Silk Route in the history. Ultimately, this paper preliminarily figure out basic information of exotic medicine of different dynasty in China,that provide reference for learning study and decision of industrial development.

[Endangered situation and conservation strategy of Tibetan medicine in Qinghai-Tibet Plateau].

With the rapid development of Tibetan medicine industry, the study on plateau medicinal plants' endangered status is not enough, measures to protect is weak and the plateau ecological environment' inherent vulnerability, resulted in the shortage of Tibetan medicinal resources and affect the sustainable development . According to the existing endangered information of Tibetan medicine resources, how to formulate feasible protection plan, is an urgent problem of the rational development and utilization of Tibetan medicine resources to be solved. To find out the endangered Tibetan medicines in Qinghai Tibet Plateau, the Grade division method of Chinese Rare and Endangered Plants was applied, the endangered species were sorted out, which divided into class one (threatened) eleven species, class two (rare) twenty-one species, and class three (fading) forty-two species,a total of seventy-four species.In addition to national protection list in "Chinese rare and endangered plants". It's proposed to increase the endangered Tibetan medicinal species. Finally, according to the endangered status of the resources,from the survey of endangered Tibetan medicinal species regularly, the germplasm repository establishment of endangered Tibetan medicine, in situ conservation, artificial cultivation research and renew the idea, reasonable development and utilization, a total of 5 aspects to discussed the protection strategy, to provide a scientific basis for the protection and sustainable utilization of Tibetan medicine resources in Qinghai-Tibet Plateau.

[Advances of species identification and quality control for Tibetan medicines].

Species identification and quality control of Tibetan medicines are an important part of its modernization studies, and they have important significance for ensuring the safety and effectiveness of Tibetan medicines in clinical application. In order to provide a reference for the modernization research of Tibetan medicines, this paper summarized the research progress of species identification, quality standards and quality evaluation of Tibetan medicines in the past 10 years. It also introduces the application examples of some new technologies and methods, such as DNA barcoding, infrared spectroscopy and 1H NMR-based metabolomics.

[Research progress on resources and quality evaluation of Tibetan medicine in Qinghai-Tibet Plateau].

With the development of Tibetan medicine industry, the demands for Tibetan medicine were rising sharply. In addition, with the eco-environment vulnerability of Qinghai-Tibet Plateau region and the phenomenon of synonymies and homonymies in Tibetan medicine, there were a lack of resources and varieties in the clinical application of Tibetan medicine. At present, the shortage of Tibetan medicine and the inadequacy of its quality standard have become the two major problems that seriously restricted the sustainable development of Tibetan medicine industry. Therefore, it is important to develop the resources investigation and quality evaluation for Tibetan medicine, which were contribute to its resources protection and sustainable utilization. In this paper, current status of resources investigation, quality standardization, artificial breeding and germplasm resources of Tibetan medicine were presented by the integrated application of the new technologies, such as DNA barcoding and 1H-NMR, which provided a reference information for resources protection, sustainable utilization, variety identification and quality standardization of Tibetan medicine resources in Qinghai-Tibet Plateau.

[Preliminary discussion on an overview of ethnic minority use of species of mineral medicine].

As an indispensable part of minority traditional medicine, mineral medicine has used with less dosage and reliable efficacy for the last thousand years. Based on the unearthed relics and medical literatures of past dynasties, the history of Han nationality ap- years, which had been recorded in main literature. But there is less comprehensive report of its usage in the other 55-minority nationality. This article was based on the analysis of ethnic minority literature of thousands of years, and conducted a comprehensive collation and analysis of mineral medicine. It was mostly determined that there was 20 minority groups using mineral medicine, with a total of 163 species (limited our references), and the most used is the Tibetan, accounting for 141. The most serious problems of mineral medicine are that species should be further investigated and researched, and then become the legal commercial medicine, and the classification principles of mineral medicine should be established. Through the traditional processing and experimental studies, the problems of attenuation and detoxification should be solved.

[Study of Rhizoma chuanxiong storage conditions].

OBJECTIVE: To study the different packing and storage life effect on the content of effective element in Rhizoma Chuanxiong, so as to guide the packing, moist, volatile oil and ferulic acid in Rhizoma Chuanxiong from two GAP base by the related determination method in supplyment of China Pharmocopeia (2000). And the content of total alkaloids was determined by acid dye colorimentry. RESULTS: The loss of effective element in Rhizoma Chuanxiong was the least when in vaccum packing, sack and weave packet. During the storage the content of moist and volatile oil decreased; the content of ferulic acid increased;the content variety of total alkaloids had no regulation. CONCLUSION: We should choose the sack and weave packet as the packing of Rhizoma Chuanxiong. If the quantity is small we should use vaccum packing. Conbined the changes of Rhizoma Chuanxiong effective element and the phenomenon of mildew and worm eaten during storage, we should not store it for long time.

[The herbalogical textual research on "bai zhi"].

The folowing grounds of "Bai Zhi" (Angelica dahurica) have been researched on the herbalogy, such as medicinal and cultivated history, change of original plant, collecting time, processing method, quality assessement and medicinal part etc.

[Determination of coumarins content in Radix Angelicae dahuricae by HPLC and UV].

OBJECTIVE: To determine the coumarins content in Radix Angelicae Dahuricae (Baizhi). METHODS: The total content of coumarins was determined by UV. The content of imperatorin, isoimperatorin and oxypeucedanin hydrate in different samples was carriedut by HPLC. RESULTS: The processing method and the medicinal position have great effect on the coumarin content. CONCLUSION: The content of oxypeucedanin hydrate in Baizhi was determined. This method can be used for quality control of Baizhi.

[Study on the plant community of Fritillaria cirrhosa].

OBJECTIVE: To provide scientific basis for natural cultivation of Fritillaria cirrhosa. METHOD: The cluster analysis to the Bray--Curtis distance coefficient of community plot was carried out to divide the community types of F. cirrhosa. RESULT AND CONCLUSION: The community of F. cirrhosa's natural cultivation can be divided into six types: Sibiraea angustata community, Rhododendron litangense community, Salix sclerophylla community, Dasiphora fruticosa + Spiraea alpina + S. myrtilloides community, Sabina pingii var. wilsonii community, Polygonum viviparum + P. sphaerostachyum community, and the ecological characteristics such as the composition of community and ecological distribution have been showed.